{"id":96517,"date":"2025-08-20T09:52:10","date_gmt":"2025-08-20T09:52:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/96517\/"},"modified":"2025-08-20T09:52:10","modified_gmt":"2025-08-20T09:52:10","slug":"genetic-technologies-enters-voluntary-administration-sells-genetype-business","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/96517\/","title":{"rendered":"Genetic Technologies Enters Voluntary Administration, Sells geneType Business"},"content":{"rendered":"<p>Elevate Your Investing Strategy: Take advantage of <a data-link=\"article_promo\" href=\"https:\/\/lp.tipranks.com\/july-2025-50off\/?llf=rss&amp;timer=on&amp;coupon=INTRO50P\" rel=\"nofollow noopener\" target=\"_blank\"> TipRanks Premium at 50% off! <\/a> Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.<\/p>\n<p>Genetic Technologies ( <a data-ticker=\"AU:GTG\" href=\"https:\/\/www.tipranks.com\/stocks\/au:gtg\" rel=\"nofollow noopener\" target=\"_blank\">(AU:GTG)<\/a> ) just unveiled an update.<\/p>\n<p>Genetic Technologies Limited has entered voluntary administration after failing to secure necessary capital and strategic partnerships, despite efforts to restructure and focus on US sales growth. The company has sold its geneType business to Rhythm Biosciences Limited for $625,000, a move that includes the transfer of intellectual property, assets, and employees, while administrators continue to explore options for the company\u2019s future.<\/p>\n<p>More about Genetic Technologies<\/p>\n<p>Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its geneType product line, which provides genetic risk assessment tools, primarily targeting the US market.<\/p>\n<p>Technical Sentiment Signal: Sell<\/p>\n<p>Current Market Cap: A$5.67M<\/p>\n<p>Learn more about GTG stock on <a href=\"https:\/\/www.tipranks.com\/stocks\/au:gtg\" target=\"_blank\" rel=\"nofollow noopener\">TipRanks\u2019 Stock Analysis page<\/a>.<\/p>\n<p><a href=\"https:\/\/www.tipranks.com\/glossary\/d\/disclaimer-disclosure\" style=\"margin-right: 32px;\" rel=\"nofollow noopener\" target=\"_blank\">Disclaimer &amp; Disclosure<\/a><a href=\"https:\/\/www.tipranks.com\/glossary\/c\/contact-editor\" rel=\"nofollow noopener\" target=\"_blank\">Report an Issue<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data,&hellip;\n","protected":false},"author":2,"featured_media":96518,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[200,79],"class_list":["post-96517","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetics","tag-genetics","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/96517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=96517"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/96517\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/96518"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=96517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=96517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=96517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}